Artiklar med krav på offentlig åtkomst - Dr. Rohan Gupta, Ph.D.Läs mer
Inte tillgängliga någonstans: 6
New era of artificial intelligence and machine learning-based detection, diagnosis, and therapeutics in Parkinson’s disease
R Gupta, S Kumari, A Senapati, RK Ambasta, P Kumar
Ageing research reviews, 102013, 2023
Krav: Department of Biotechnology, India
Can luteolin be a therapeutic molecule for both colon cancer and diabetes?
RK Ambasta, R Gupta, D Kumar, S Bhattacharya, A Sarkar, P Kumar
Briefings in Functional Genomics 18 (4), 230-239, 2019
Krav: Council of Scientific and Industrial Research, India, Department of Science …
Free radical biology in neurological manifestations: mechanisms to therapeutics interventions
R Tripathi, R Gupta, M Sahu, D Srivastava, A Das, RK Ambasta, P Kumar
Environmental Science and Pollution Research, 1-48, 2021
Krav: Department of Biotechnology, India
Multiple therapeutic approaches of glioblastoma multiforme: From terminal to therapy
S Kumari, R Gupta, RK Ambasta, P Kumar
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1878 (4), 188913, 2023
Krav: Department of Biotechnology, India
Protective role of anticancer drugs in neurodegenerative disorders: A drug repurposing approach
D Advani, R Gupta, R Tripathi, S Sharma, RK Ambasta, P Kumar
Neurochemistry International 140, 104841, 2020
Krav: Department of Biotechnology, India
Emerging trends in post-translational modification: Shedding light on Glioblastoma multiforme
S Kumari, R Gupta, RK Ambasta, P Kumar
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1878 (6), 188999, 2023
Krav: Department of Biotechnology, India
Publikations- och finansieringsuppgifter tas fram automatiskt av ett datorprogram.